1. Novel oral treatment of Gaucher's disease with N-butyledeoxynojirimicin (OGT 918) to decrease substrate biosynthesis;Cox;Lancet,2000
2. New therapeutic prospects for the glycosingolipid lycosomal storage diseases;Platt;Biochem Pharmacol,1998
3. Prevention of lycosomal storage in Tay-Sachs mice treated with N-butyledeoxynojirimicin;Platt;Science,1997
4. The safety and efficacy of combination N-butyl-deoxynojirimicin (SC-48334) and zidovudine in patients with HIV-1 infection and 200–500 CD4 cells/mm3;Fischl;J Acquir Immune Defic Syndr Hum Retrovirol,1994
5. Enzyme therapy for Gaucher disease: the first 5 years;Grabowski;Blood Rev,1998